1 results match your criteria: "Tianjin Clinical Medical Research Center of Malignant Tumors[Affiliation]"
Zhonghua Yi Xue Za Zhi
January 2019
Department of Interventional Therapy, Affiliated Tumor Hospital of Tianjin Medical University, National Clinical Medical Research Center of Cancer, Tianjin Municipal Key Laboratory of Cancer Prevention and Treatment, Tianjin Clinical Medical Research Center of Malignant Tumors, Tianjin 300060, China.
To evaluate the efficacy and safety of dexmedetomidine as a basic analgesic sedative for patients with radiofrequency ablation of liver tumors. A total of 443 liver cancer patients underwent percutaneous radiofrequency ablation in the 302 Hospital of PLA from January 2015 to December 2016 were retrospectively studied. The experimental group was dexmedetomidine group, with a total of 165 cases.
View Article and Find Full Text PDF